Sanofi India Offloads Nutraceuticals Business To Local Player
Sanofi India – in which France’s Sanofi S.A. holds a controlling 60% stake – is to divest its Nutraceuticals business in a deal worth around $80m.
You may also be interested in...
Germany's Stada is strengthening its portfolio by taking over distribution of 50 well-established Sanofi Consumer Healthcare brands marketed across Europe.
Sanofi says a double-digit gain for its Consumer Healthcare business in Q2 is evidence its new category prioritization strategy is paying off.
Sanofi will look to offload around 150 OTC brands as part of a radical overhaul of its Consumer Healthcare operation. The new head of the business Julie Van Ongevalle has unveiled a wide-ranging turnaround plan with the goal of transforming Sanofi into the OTC market leader.